Tanreqing Recent clinical application of injection.docVIP

 PAGE \* MERGEFORMAT 44 Tanreqing Recent clinical application of injection Keywords: Tanreqing injection; clinical application of Tanreqing injection from the Kai Bao Pharmaceutical Ltd., has exclusive intellectual property of the State Chinese Medicine second-class medicine, from baicalin, bear bile powder, goat angle, honeysuckle, forsythia and other scientific group of parties, strict fingerprints of traditional Chinese medicine made in accordance with the production, with anti-viral, antibacterial, anti-inflammatory, antipyretic, expectorant cough and other role, since listing has been widely used in clinical diseases. Now on its clinical application are summarized below. An upper respiratory tract infection Upper respiratory tract infections are the most common form of respiratory tract infectious disease, about 70% ~ 80% caused by a virus [1]. Min Cun-Yun et al [2] will Tanreqing for acute upper respiratory tract infection, in order to observe its acute upper respiratory tract infection therapeutic effect. Studies have shown that Tanreqing acute upper respiratory tract infection have a good therapeutic effect, efficiency of 86.7%, and antimicrobial agents at the same time a new application of Fuxin rate was 98.3% more effective than single drugs. Especially in the antipyretic, cough has a good effect. Ling Ju-fang [3] due to acute upper respiratory tract infection in 152 cases were randomly divided into two groups, treatment group, 80 patients with Tanreqing injection therapy; control group, 72 patients with Yuxingcao injection. The results showed that the treatment group, the total effective rate was 93.3% in the control group, the total effective rate was 80.6%, by Ridit analysis, treatment group was more effective than the control group. Huang Ying [4] will Tanreqing Injection 20 ml by adding 10% glucose injection or normal saline 250 ml for 30 cases of upper respiratory tract infection in elderly patients with intra